《International Journal Of Technology Assessment In Health Care》雜志的收稿范圍和要求是什么?
來(lái)源:優(yōu)發(fā)表網(wǎng)整理 2024-09-18 10:59:16 684人看過(guò)
《International Journal Of Technology Assessment In Health Care》雜志收稿范圍涵蓋醫(yī)學(xué)全領(lǐng)域,此刊是該細(xì)分領(lǐng)域中屬于非常不錯(cuò)的SCI期刊,在行業(yè)細(xì)分領(lǐng)域中學(xué)術(shù)影響力較大,專業(yè)度認(rèn)可很高,所以對(duì)原創(chuàng)文章要求創(chuàng)新性較高,如果您的文章質(zhì)量很高,可以嘗試。
平均審稿速度 較慢,6-12周 ,影響因子指數(shù)2.6。
該期刊近期沒(méi)有被列入國(guó)際期刊預(yù)警名單,廣大學(xué)者值得一試。
具體收稿要求需聯(lián)系雜志社或者咨詢本站客服,在線客服團(tuán)隊(duì)會(huì)及時(shí)為您答疑解惑,提供針對(duì)性的建議和解決方案。
出版商聯(lián)系方式:CAMBRIDGE UNIV PRESS, 32 AVENUE OF THE AMERICAS, NEW YORK, USA, NY, 10013-2473
其他數(shù)據(jù)
是否OA開(kāi)放訪問(wèn): | h-index: | 年文章數(shù): |
未開(kāi)放 | 63 | 70 |
Gold OA文章占比: | 2021-2022最新影響因子(數(shù)據(jù)來(lái)源于搜索引擎): | 開(kāi)源占比(OA被引用占比): |
48.00% | 2.6 | 0.35... |
研究類文章占比:文章 ÷(文章 + 綜述) | 期刊收錄: | 中科院《國(guó)際期刊預(yù)警名單(試行)》名單: |
78.57% | SCIE | 否 |
歷年IF值(影響因子):
歷年引文指標(biāo)和發(fā)文量:
歷年中科院JCR大類分區(qū)數(shù)據(jù):
歷年自引數(shù)據(jù):
發(fā)文統(tǒng)計(jì)
2023-2024國(guó)家/地區(qū)發(fā)文量統(tǒng)計(jì):
國(guó)家/地區(qū) | 數(shù)量 |
Canada | 56 |
England | 42 |
Netherlands | 32 |
Australia | 29 |
USA | 28 |
Spain | 23 |
GERMANY (FED REP GER) | 21 |
France | 17 |
Italy | 12 |
Belgium | 10 |
2023-2024機(jī)構(gòu)發(fā)文量統(tǒng)計(jì):
機(jī)構(gòu) | 數(shù)量 |
RADBOUD UNIVERSITY NIJMEGEN | 15 |
UNIVERSITY OF ADELAIDE | 12 |
UNIVERSITY OF BARCELONA | 12 |
UNIVERSITY OF LONDON | 12 |
UNIVERSITY OF TORONTO | 12 |
NATIONAL INSTITUTE FOR HEALTH & ... | 11 |
MAASTRICHT UNIVERSITY | 9 |
MCMASTER UNIVERSITY | 8 |
CATHOLIC UNIVERSITY OF THE SACRE... | 7 |
ASSISTANCE PUBLIQUE HOPITAUX PAR... | 6 |
近年引用統(tǒng)計(jì):
期刊名稱 | 數(shù)量 |
INT J TECHNOL ASSESS | 165 |
VALUE HEALTH | 66 |
PHARMACOECONOMICS | 42 |
BMJ-BRIT MED J | 28 |
HEALTH ECON | 26 |
HEALTH POLICY | 25 |
MED DECIS MAKING | 25 |
BMC HEALTH SERV RES | 24 |
ANN RHEUM DIS | 21 |
HEALTH TECHNOL ASSES | 21 |
近年被引用統(tǒng)計(jì):
期刊名稱 | 數(shù)量 |
INT J TECHNOL ASSESS | 165 |
VALUE HEALTH | 71 |
BMJ OPEN | 69 |
HEALTH POLICY | 57 |
BMC HEALTH SERV RES | 48 |
PLOS ONE | 45 |
APPL HEALTH ECON HEA | 34 |
PHARMACOECONOMICS | 29 |
COCHRANE DB SYST REV | 28 |
EXPERT REV PHARM OUT | 27 |
近年文章引用統(tǒng)計(jì):
文章名稱 | 數(shù)量 |
COSTS OF HOME-BASED TELEMEDICINE... | 16 |
REAL-WORLD CLINICAL EVALUATION A... | 9 |
CHARACTERISTICS OF MANAGED ENTRY... | 8 |
SUITABILITY OF CURRENT EVALUATIO... | 7 |
SYSTEMATIC REVIEW WITH NETWORK M... | 6 |
HEALTH TECHNOLOGY ASSESSMENT MET... | 5 |
SUCCESSFUL IMPLEMENTATION OF LEA... | 5 |
COST-UTILITY ANALYSIS OF MULTIPL... | 5 |
How Procurement Judges The Value... | 5 |
Population Adjustment Methods fo... | 5 |
聲明:以上內(nèi)容來(lái)源于互聯(lián)網(wǎng)公開(kāi)資料,如有不準(zhǔn)確之處,請(qǐng)聯(lián)系我們進(jìn)行修改。